CD8<sup>+</sup> T cells: An ineffective armor against prolonged COVID-19 in cancer patients.
Where this comes from
- Record sourced from PubMed, PMID 35835105.
- Also identified by DOI 10.1016/j.xcrm.2022.100695 and PMC identifier 9233996.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a diverse cohort of cancer patients, Lyudovyk et al.<sup>1</sup> show that persistent COVID-19 infection is associated with weaker humoral responses and increased CD8<sup>+</sup> T cell responses that are ineffective in clearing virus, particularly in patients receiving B cell-depleting therapies.
Medical subject headings
- COVID-19
- Neoplasms